A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03355066 |
Recruitment Status :
Active, not recruiting
First Posted : November 28, 2017
Last Update Posted : October 19, 2022
|
Sponsor:
Biosplice Therapeutics, Inc.
Information provided by (Responsible Party):
Biosplice Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | December 2023 |
Estimated Study Completion Date : | December 2025 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):